BIOMAT Database Logo BIOMAT Database Logo

Synthesis and biological evaluation of celastrol derivatives as anti-ovarian cancer stem cell agents. 2019

Xiaojing Li, and Jie Ding, and Ning Li, and Wenxia Liu, and Fuhao Ding, and Huijuan Zheng, and Yanyan Ning, and Hongmin Wang, and Renmin Liu, and Shaoda Ren
School of Pharmacy, Liaocheng University, Shandong, 252000, People's Republic of China. Electronic address: lixiaojing@lcu.edu.cn.

Ovarian cancer is associated with a high percentage of recurrence of tumors and resistance to chemotherapy. Cancer stem cells (CSCs) are responsible for cancer progression, tumor recurrence, metastasis, and chemoresistance. Thus, developing CSC-targeting therapy is an urgent need in cancer research and clinical application. In an attempt to achieve potent and selective anti-CSC agents, a series of celastrol derivatives with cinnamamide chains were synthesized and evaluated for their anti-ovarian cancer activities. Most of the compounds exhibited stronger antiproliferative activity than celastrol, and celastrol derivative 7g with a 3,4,5-trimethoxycinnamamide side chain was found to be the most potent antiproliferative agent against ovarian cancer cells with an IC50 value of 0.6 μM. Additionally, compound 7g significantly inhibited the colony formation ability and reduced the number of tumor spheres. Furthermore, compound 7g decreased the percentage of CD44+, CD133+ and ALDH+ cells. Thus, compound 7g is a promising anti-CSC agent and could serve as a candidate for the development of new anti-ovarian cancer drugs.

UI MeSH Term Description Entries
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014315 Triterpenes A class of terpenes (the general formula C30H48) formed by the condensation of six isoprene units, equivalent to three terpene units. Triterpene,Triterpenoid,Triterpenoids

Related Publications

Xiaojing Li, and Jie Ding, and Ning Li, and Wenxia Liu, and Fuhao Ding, and Huijuan Zheng, and Yanyan Ning, and Hongmin Wang, and Renmin Liu, and Shaoda Ren
Synthesis and Biological Evaluation of Celastrol Derivatives as Potential Immunosuppressive Agents.
September 2020, Journal of natural products,
Xiaojing Li, and Jie Ding, and Ning Li, and Wenxia Liu, and Fuhao Ding, and Huijuan Zheng, and Yanyan Ning, and Hongmin Wang, and Renmin Liu, and Shaoda Ren
Synthesis and biological evaluation of indazole derivatives as anti-cancer agents.
April 2021, RSC advances,
Xiaojing Li, and Jie Ding, and Ning Li, and Wenxia Liu, and Fuhao Ding, and Huijuan Zheng, and Yanyan Ning, and Hongmin Wang, and Renmin Liu, and Shaoda Ren
Synthesis and biological evaluation of matrine derivatives as anti-hepatocellular cancer agents.
September 2016, Bioorganic & medicinal chemistry letters,
Xiaojing Li, and Jie Ding, and Ning Li, and Wenxia Liu, and Fuhao Ding, and Huijuan Zheng, and Yanyan Ning, and Hongmin Wang, and Renmin Liu, and Shaoda Ren
Synthesis and biological evaluation of Schizandrin derivatives as potential anti-cancer agents.
April 2018, European journal of medicinal chemistry,
Xiaojing Li, and Jie Ding, and Ning Li, and Wenxia Liu, and Fuhao Ding, and Huijuan Zheng, and Yanyan Ning, and Hongmin Wang, and Renmin Liu, and Shaoda Ren
Design, synthesis and biological evaluation of C6-modified celastrol derivatives as potential antitumor agents.
July 2014, Molecules (Basel, Switzerland),
Xiaojing Li, and Jie Ding, and Ning Li, and Wenxia Liu, and Fuhao Ding, and Huijuan Zheng, and Yanyan Ning, and Hongmin Wang, and Renmin Liu, and Shaoda Ren
Synthesis and biological evaluation of celastrol derivatives as potent antitumor agents with STAT3 inhibition.
December 2022, Journal of enzyme inhibition and medicinal chemistry,
Xiaojing Li, and Jie Ding, and Ning Li, and Wenxia Liu, and Fuhao Ding, and Huijuan Zheng, and Yanyan Ning, and Hongmin Wang, and Renmin Liu, and Shaoda Ren
Synthesis and biological evaluation of arylpiperazine derivatives as potential anti-prostate cancer agents.
January 2019, Bioorganic & medicinal chemistry,
Xiaojing Li, and Jie Ding, and Ning Li, and Wenxia Liu, and Fuhao Ding, and Huijuan Zheng, and Yanyan Ning, and Hongmin Wang, and Renmin Liu, and Shaoda Ren
The synthesis and biological evaluation of sanguinarine derivatives as anti-non-small cell lung cancer agents.
February 2020, RSC medicinal chemistry,
Xiaojing Li, and Jie Ding, and Ning Li, and Wenxia Liu, and Fuhao Ding, and Huijuan Zheng, and Yanyan Ning, and Hongmin Wang, and Renmin Liu, and Shaoda Ren
Synthesis and biological evaluation of pyranoisoflavone derivatives as anti-inflammatory agents.
September 2014, Fitoterapia,
Xiaojing Li, and Jie Ding, and Ning Li, and Wenxia Liu, and Fuhao Ding, and Huijuan Zheng, and Yanyan Ning, and Hongmin Wang, and Renmin Liu, and Shaoda Ren
Synthesis and biological evaluation of pyranocarbazole derivatives as Anti-tumor agents.
February 2021, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!